ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 146 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $171,123 | -53.7% | 57,041 | -42.3% | 0.00% | – |
| Q2 2023 | $369,752 | +109.0% | 98,864 | +87.2% | 0.00% | – |
| Q1 2023 | $176,923 | -51.1% | 52,813 | -29.8% | 0.00% | – |
| Q4 2022 | $361,881 | +311.2% | 75,235 | +388.0% | 0.00% | – |
| Q3 2022 | $88,000 | +10.0% | 15,417 | +37.0% | 0.00% | – |
| Q2 2022 | $80,000 | -61.7% | 11,251 | -61.2% | 0.00% | – |
| Q1 2022 | $209,000 | -77.6% | 29,005 | -72.3% | 0.00% | – |
| Q4 2021 | $935,000 | -58.1% | 104,721 | +64.4% | 0.00% | -100.0% |
| Q3 2021 | $2,233,000 | -84.6% | 63,687 | -90.6% | 0.00% | -80.0% |
| Q2 2021 | $14,501,000 | +6373.7% | 675,109 | +18518.6% | 0.01% | – |
| Q1 2021 | $224,000 | -49.3% | 3,626 | -65.7% | 0.00% | – |
| Q4 2020 | $442,000 | – | 10,570 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |